From the outset in 2005, EirGen’s strength has always been rooted in the manufacture of High Potency Oral Solid Dose medicines. Our commercial facility was designed and constructed specifically for high potency manufacture and has capabilities to produce cytotoxic, genotoxic and moisture-sensitive drug products across multiple platforms. Before they are introduced onsite, all molecules undergo detailed, molecule-specific toxicology and occupational health assessments and we currently manufacture OEB 3 & 4 products (Safebridge) for both human (including paediatric) and animal health.
